Depressive Disorders - Egypt

  • Egypt
  • Revenue in the Depressive Disorders market is projected to reach US$182.90m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.03%, resulting in a market volume of US$202.20m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
  • In relation to total population figures, per person revenues of US$31.30 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Depressive Disorders market in Egypt is experiencing significant growth and development, driven by several key factors.

Customer preferences:
In Egypt, there is a growing awareness and understanding of mental health issues, including depressive disorders. As a result, there is an increasing demand for effective treatments and therapies for depression. Customers are seeking out a range of options, from pharmaceutical medications to psychotherapy and alternative therapies. This preference for a holistic approach to treating depressive disorders is driving the market forward.

Trends in the market:
One of the key trends in the Depressive Disorders market in Egypt is the rising use of antidepressant medications. As more people seek treatment for depression, there is a growing demand for pharmaceutical solutions. This trend is further fueled by the availability of a wider range of antidepressant medications in the market, providing customers with more options to choose from. Additionally, there is a growing trend towards the use of psychotherapy as a complementary treatment to medication, as customers recognize the importance of addressing both the biological and psychological aspects of depression.

Local special circumstances:
Egypt has a relatively high prevalence of depressive disorders, which contributes to the growth of the market. The country faces various social and economic challenges, such as high unemployment rates and political instability, which can contribute to higher levels of stress and depression among the population. The cultural stigma surrounding mental health issues is also starting to diminish, leading to increased acceptance and willingness to seek treatment for depressive disorders.

Underlying macroeconomic factors:
The growing Depressive Disorders market in Egypt is also influenced by several macroeconomic factors. The country has been experiencing steady economic growth in recent years, leading to an increase in disposable income and healthcare expenditure. This allows individuals to afford the cost of treatment for depressive disorders, including medication and therapy. Furthermore, the government has been taking steps to improve access to mental healthcare services, including the integration of mental health into primary care and the expansion of mental health facilities across the country. These initiatives have helped to increase the availability and accessibility of treatment options for depressive disorders, further driving the growth of the market.In conclusion, the Depressive Disorders market in Egypt is experiencing significant growth and development, driven by increasing customer awareness and demand for effective treatments. The market is characterized by a preference for a holistic approach to treating depressive disorders, with customers seeking out a range of options including medication and psychotherapy. The local special circumstances, such as a high prevalence of depressive disorders and a diminishing cultural stigma, contribute to the growth of the market. Additionally, underlying macroeconomic factors such as economic growth and government initiatives to improve access to mental healthcare services further drive the development of the market.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)